相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison
Simone Boehrer et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Lessons from congenital neutropenia: 50 years of progress in understanding myelopoiesis
Nancy Berliner
BLOOD (2008)
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray
Norihiko Kawamata et al.
BLOOD (2008)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
Guillermo Garcia-Manero et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency
Jacob Hanna et al.
CELL (2008)
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming
Rudolf Jaenisch et al.
CELL (2008)
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells
Tobias Brambrink et al.
CELL STEM CELL (2008)
Retinoic acid receptors, hematopoiesis and leukemogenesis
Steven J. Collins
CURRENT OPINION IN HEMATOLOGY (2008)
Developmental plasticity of lymphocytes
Cesar Cobaleda et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Demethylating agents in myeloid malignancies
Guillermo Garcia-Manero
CURRENT OPINION IN ONCOLOGY (2008)
Multiple ways of C/EBPα inhibition in myeloid leukaemia
A. K. Trivedi et al.
EUROPEAN JOURNAL OF CANCER (2008)
Efficient retroviral transduction of human B-lymphoid and myeloid progenitors:: marked inhibition of their growth by the Pax5 transgene
Rieko Sekine et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Meeting report: myelodysplastic syndromes at ASH 2007
R. Itzykson et al.
LEUKEMIA (2008)
Vitamin D compounds and myelodysplastic syndrome
Ryoko Okamoto et al.
LEUKEMIA & LYMPHOMA (2008)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Timothy J. Ley et al.
NATURE (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation
Maria E. Figueroa et al.
PLOS ONE (2008)
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray
Norihiko Kawamata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease
Marius Wernig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Erlotinib exhibits antineoplastic off-target effects in AML and MDS:: a preclinical study
Simone Boehrer et al.
BLOOD (2008)
The regulation of the B-cell gene expression programme by Pax5
Melissa L. Holmes et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Jacob Hanna et al.
SCIENCE (2007)
Synergistic effects of RXRα and PPARγ ligands to inhibit growth in human colon cancer cells -: phosphorylated RXRα is a critical target for colon cancer management
Kenji Yamazaki et al.
GUT (2007)
Transcriptional dysregulation during myeloid transformation in AML
T. Pabst et al.
ONCOGENE (2007)
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors
Cesar Cobaleda et al.
NATURE (2007)
Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non-small-cell lung cancer
Geoffrey Chan et al.
BLOOD (2007)
Generation of germline-competent induced pluripotent stem cells
Keisuke Okita et al.
NATURE (2007)
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Marius Wernig et al.
NATURE (2007)
RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells
Hidenori Hattori et al.
BLOOD (2007)
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Nimet Maherali et al.
CELL STEM CELL (2007)
Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes
Kristina Anderson et al.
BLOOD (2007)
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2007)
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation
Sigal Gery et al.
EXPERIMENTAL HEMATOLOGY (2007)
Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues
Adrian F. Gombart et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Pilot study of rosiglitazone therapy in women with breast cancer: Effects of short-term therapy on tumor tissue and serum markers
Lisa D. Yee et al.
CLINICAL CANCER RESEARCH (2007)
Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobuhn heavy-chain locus
Abdallah Souabni et al.
BLOOD (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation human myeloid leukemia cells
Bulent Ozpolat et al.
MOLECULAR CANCER RESEARCH (2007)
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia
Raffaella Villa et al.
CANCER CELL (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia
Karen Keeshan et al.
CANCER CELL (2006)
Dual PPAR α/γ ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines
Chuanbing Zang et al.
CELL CYCLE (2006)
Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;: Pten mutant mice
Whitney Banach-Petrosky et al.
CLINICAL CANCER RESEARCH (2006)
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia
Giuseppe Cimino et al.
CANCER RESEARCH (2006)
Differentiation and growth inhibition mediated via the RXR:PPARγ heterodimer in colon cancer
Rosemary M. Cesario et al.
CANCER LETTERS (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
E Estey et al.
BLOOD (2006)
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression
BU Mueller et al.
BLOOD (2006)
Peroxisome proliferator-activated receptor γ in malignant diseases
TT Wang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Role of cytokines in the treatment of acute leukemias:: a review
F Ravandí
LEUKEMIA (2006)
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
V Mathews et al.
BLOOD (2006)
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein
R Carbone et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
A Ghavamzadeh et al.
ANNALS OF ONCOLOGY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Vitamin D2 analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome
HP Koeffler et al.
LEUKEMIA RESEARCH (2005)
Gefitinib induces myeloid differentiation of acute myeloid leukemia
K Stegmaier et al.
BLOOD (2005)
Peroxisome proliferator-activated receptor γ agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in Apc1638 N/+ Mlh1+/- double mutant mice
K Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3
AF Gombart et al.
FASEB JOURNAL (2005)
Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia
PZ Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia
W Matsui et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPAR-γ
CW Shiau et al.
CANCER RESEARCH (2005)
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
S Sakajiri et al.
EXPERIMENTAL HEMATOLOGY (2005)
PPARγ signaling exacerbates mammary gland tumor development
E Saez et al.
GENES & DEVELOPMENT (2004)
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
JPJ Issa et al.
BLOOD (2004)
Cutting edge:: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression
TT Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
Phosphorylation of C/EBP alpha inhibits granulopoiesis
SE Ross et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Restoration of C/EBPα expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation
S Tavor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Comparative analysis of genes regulated by PML/RARα and PLZF/RARα response to retinoic acid using oligonucleotide arrays
DJ Park et al.
BLOOD (2003)
A phase II trial with rosiglitazone in liposarcoma patients
G Debrock et al.
BRITISH JOURNAL OF CANCER (2003)
Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor γ in the MCF-7 breast cancer cell line
M Pignatelli et al.
ONCOGENE (2003)
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
HJ Burstein et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Disruption of differentiation in human cancer: AML shows the way
DG Tenen
NATURE REVIEWS CANCER (2003)
All-trans retinoic acid in acute promyelocytic leukemia:: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
MS Tallman et al.
BLOOD (2002)
Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia
CS Chim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
M Daskalakis et al.
BLOOD (2002)
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ
T Zander et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Transcriptional regulation of granulocyte and monocyte development
AD Friedman
ONCOGENE (2002)
Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice
J O'Kelly et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
IL-6 induces expression of the Fli-1 proto-oncogene via STAT3
DR Hodge et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia
S Kitareewan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias
AF Gombart et al.
BLOOD (2002)
Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor
L Di Croce et al.
SCIENCE (2002)
Arsenic trioxide, a therapeutic agent for APL
TD Zhang et al.
ONCOGENE (2001)
Inhibitory effects of 1α,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery
SS Jensen et al.
MOLECULAR ENDOCRINOLOGY (2001)
Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN
L Patel et al.
CURRENT BIOLOGY (2001)
AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
T Pabst et al.
NATURE MEDICINE (2001)
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
T Pabst et al.
NATURE GENETICS (2001)
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
A Chawla et al.
NATURE MEDICINE (2001)
1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo
DJ Mantell et al.
CIRCULATION RESEARCH (2000)
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid:: effects in patients with newly diagnosed acute promyelocytic leukemia
E Lengfelder et al.
LEUKEMIA (2000)
分享论文
